![M. Alexander Shaw](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
M. Alexander Shaw
No open positions remaining
Profile
M.
Alexander Shaw formerly worked at Prolifagen, Inc., as Chief Executive Officer and Nuventra, Inc., as Chief Operating Officer from 2009 to 2021.
Dr. Shaw received his undergraduate degree from Duke University and doctorate degree from Washington State University.
Former positions of M. Alexander Shaw
| Companies | Position | End |
|---|---|---|
Nuventra, Inc.
 Nuventra, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical pharmacology consulting firm | Chief Operating Officer | 30/09/2021 |
Prolifagen LLC
 Prolifagen LLC BiotechnologyHealth Technology Develops ribonucleic acid therapeutics intended for cardiac tissue regeneration | Chief Executive Officer | - |
Training of M. Alexander Shaw
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
5
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Washington State University
 Washington State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nuventra, Inc.
Nuventra, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical pharmacology consulting firm | Commercial Services |
Prolifagen LLC
Prolifagen LLC BiotechnologyHealth Technology Develops ribonucleic acid therapeutics intended for cardiac tissue regeneration | Health Technology |
- Stock Market
- Insiders
- M. Alexander Shaw
Choose MarketScreener 
